ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

No reading has been made of this study yet; what is shown is how the rules link it today.

8 links0 made here, not in the record8 judgments1 judge (the rules as one: Rule based)0 record changes seen
Rule based
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT00790439Safety and Effectiveness ofLow Molecular WeightSulfated Dextran in IsletTransplantation AfterKidney TransplantNational Institute of Allergy Phase 2 · withdrawnRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSDiabetes Mellitus, Type 1The registry's MeSH filing›As of now · Rule based · Main conditionMain conditionDRUGSHeparinIntervention entry›As of now · Rule based · ComparatorComparatorMycophenolic AcidEntry “Mycophenolate Mofetil”, read b…›As of now · Rule based · BackgroundBackgroundSirolimusIntervention entry›As of now · Rule based · BackgroundBackgroundTacrolimusIntervention entry›As of now · Rule based · BackgroundBackgroundCyclosporineIntervention entry›As of now · Rule based · BackgroundBackgroundDaclizumabIntervention entry›As of now · Rule based · BackgroundBackgroundBasiliximabIntervention entry›As of now · Rule based · BackgroundBackground

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Diabetes Mellitus, Type 1

From the registry record1 judgment on this link
Main condition (R9), from the registry to what was judged
RegistryDiabetes Mellitus, Type 1, as filedthe registry files the study under it
→judged

All judgments on this study

WhenLinkJudgeDecisionState
As of nowDiabetes Mellitus, Type 1Rule based · main-condition ruleMain conditionCurrent
As of nowHeparinRule based · role ruleComparatorCurrent
As of nowMycophenolic AcidRule based · role ruleBackgroundCurrent
As of nowSirolimusRule based · role ruleBackgroundCurrent
As of nowTacrolimusRule based · role ruleBackgroundCurrent
As of nowCyclosporineRule based · role ruleBackgroundCurrent
As of nowDaclizumabRule based · role ruleBackgroundCurrent
As of nowBasiliximabRule based · role ruleBackgroundCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.